Annual CFO
-$207.82 M
-$44.07 M-26.91%
December 31, 2023
Summary
- As of February 7, 2025, ZNTL annual cash flow from operations is -$207.82 million, with the most recent change of -$44.07 million (-26.91%) on December 31, 2023.
- During the last 3 years, ZNTL annual CFO has fallen by -$121.00 million (-139.36%).
- ZNTL annual CFO is now -756.96% below its all-time high of -$24.25 million, reached on December 31, 2018.
Performance
ZNTL Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$44.05 M
-$8.91 M-25.35%
September 30, 2024
Summary
- As of February 7, 2025, ZNTL quarterly cash flow from operations is -$44.05 million, with the most recent change of -$8.91 million (-25.35%) on September 30, 2024.
- Over the past year, ZNTL quarterly CFO has dropped by -$5.38 million (-13.91%).
- ZNTL quarterly CFO is now -533.01% below its all-time high of -$6.96 million, reached on June 30, 2019.
Performance
ZNTL Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$171.76 M
-$5.38 M-3.23%
September 30, 2024
Summary
- As of February 7, 2025, ZNTL TTM cash flow from operations is -$171.76 million, with the most recent change of -$5.38 million (-3.23%) on September 30, 2024.
- Over the past year, ZNTL TTM CFO has increased by +$32.80 million (+16.03%).
- ZNTL TTM CFO is now -1807.14% below its all-time high of -$9.01 million, reached on March 31, 2019.
Performance
ZNTL TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ZNTL Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -26.9% | -13.9% | +16.0% |
| 3 y3 years | -139.4% | -13.9% | +16.0% |
| 5 y5 years | -757.0% | -13.9% | +16.0% |
ZNTL Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -34.9% | at low | -32.7% | +44.4% | -11.5% | +18.4% |
| 5 y | 5-year | -430.9% | at low | -233.9% | +44.4% | -338.8% | +18.4% |
| alltime | all time | -757.0% | at low | -533.0% | +44.4% | -1807.1% | +18.4% |
Zentalis Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$44.05 M(+25.3%) | -$171.76 M(+3.2%) |
| Jun 2024 | - | -$35.14 M(-32.4%) | -$166.38 M(-21.0%) |
| Mar 2024 | - | -$51.97 M(+28.0%) | -$210.51 M(+1.3%) |
| Dec 2023 | -$207.82 M(+26.9%) | -$40.60 M(+5.0%) | -$207.82 M(+1.6%) |
| Sep 2023 | - | -$38.66 M(-51.2%) | -$204.55 M(+2.7%) |
| Jun 2023 | - | -$79.28 M(+60.9%) | -$199.09 M(+22.3%) |
| Mar 2023 | - | -$49.28 M(+32.0%) | -$162.84 M(-0.6%) |
| Dec 2022 | -$163.75 M(+6.3%) | -$37.33 M(+12.4%) | -$163.75 M(+0.2%) |
| Sep 2022 | - | -$33.20 M(-22.8%) | -$163.44 M(-0.2%) |
| Jun 2022 | - | -$43.03 M(-14.3%) | -$163.73 M(-1.8%) |
| Mar 2022 | - | -$50.20 M(+35.6%) | -$166.82 M(+8.3%) |
| Dec 2021 | -$154.09 M | -$37.02 M(+10.5%) | -$154.09 M(+6.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$33.49 M(-27.4%) | -$144.43 M(+9.8%) |
| Jun 2021 | - | -$46.11 M(+23.1%) | -$131.50 M(+22.4%) |
| Mar 2021 | - | -$37.47 M(+37.0%) | -$107.42 M(+23.7%) |
| Dec 2020 | -$86.83 M(+121.8%) | -$27.36 M(+33.0%) | -$86.83 M(+19.5%) |
| Sep 2020 | - | -$20.56 M(-6.7%) | -$72.66 M(+17.0%) |
| Jun 2020 | - | -$22.03 M(+30.6%) | -$62.08 M(+32.1%) |
| Mar 2020 | - | -$16.87 M(+27.9%) | -$47.01 M(+20.1%) |
| Dec 2019 | -$39.14 M(+61.4%) | -$13.19 M(+32.1%) | -$39.14 M(+50.8%) |
| Sep 2019 | - | -$9.99 M(+43.5%) | -$25.95 M(+62.6%) |
| Jun 2019 | - | -$6.96 M(-22.7%) | -$15.96 M(+77.3%) |
| Mar 2019 | - | -$9.01 M | -$9.01 M |
| Dec 2018 | -$24.25 M | - | - |
FAQ
- What is Zentalis Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Zentalis Pharmaceuticals?
- What is Zentalis Pharmaceuticals annual CFO year-on-year change?
- What is Zentalis Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Zentalis Pharmaceuticals?
- What is Zentalis Pharmaceuticals quarterly CFO year-on-year change?
- What is Zentalis Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Zentalis Pharmaceuticals?
- What is Zentalis Pharmaceuticals TTM CFO year-on-year change?
What is Zentalis Pharmaceuticals annual cash flow from operations?
The current annual CFO of ZNTL is -$207.82 M
What is the all time high annual CFO for Zentalis Pharmaceuticals?
Zentalis Pharmaceuticals all-time high annual cash flow from operations is -$24.25 M
What is Zentalis Pharmaceuticals annual CFO year-on-year change?
Over the past year, ZNTL annual cash flow from operations has changed by -$44.07 M (-26.91%)
What is Zentalis Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of ZNTL is -$44.05 M
What is the all time high quarterly CFO for Zentalis Pharmaceuticals?
Zentalis Pharmaceuticals all-time high quarterly cash flow from operations is -$6.96 M
What is Zentalis Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, ZNTL quarterly cash flow from operations has changed by -$5.38 M (-13.91%)
What is Zentalis Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of ZNTL is -$171.76 M
What is the all time high TTM CFO for Zentalis Pharmaceuticals?
Zentalis Pharmaceuticals all-time high TTM cash flow from operations is -$9.01 M
What is Zentalis Pharmaceuticals TTM CFO year-on-year change?
Over the past year, ZNTL TTM cash flow from operations has changed by +$32.80 M (+16.03%)